ESTRO 2024 - Abstract Book

S2367

Clinical - Urology

ESTRO 2024

Conclusion:

This study reported, for the first time, the clinical feasibility, and preliminary outcomes of simultaneous MRgSBRT to both prostate and metastatic lesions in patients with synchronous OMPC. The early results suggested the clinical feasibility, favorable patient tolerance and toxicities, and encouraging preliminary outcomes, but yet to be further validated.

Keywords: Oligometastatic prostate cancer, MRgRT

835

Digital Poster

Early salvage radiotherapy in biochemical recurrences from prostate cancer: preliminary outcomes

Erika Galietta 1,2 , Letizia Cavallini 1,2 , Filippo Mammini 1,2 , Silvia Paolinelli 1,2 , Viola Laghi 1,2 , Elena Natoli 1,2 , Milly Buwenge 1 , Giorgio Coco 1,2 , Alessandra D'Alterio 1,2 , Pietro Del Pia 1 , Nadav Schindler 1 , Noam Shira Darnell 1 , Arthur Sarmento Pinto Yanez 1 , Patrick Duhanxhiu 1 , Sara Tamburini 3 , Angelo Mottaran 3 , Matteo Droghetti 3 , Francesco Chessa 3 , Calogero Catanzaro 3 , Lorenzo Bianchi 3 , Riccardo Schiavina 1,3 , Eugenio Brunocilla 1,3 , Maria Ntreta 2 , Alessandra Arcelli 2 , Alessio Giuseppe Morganti 1,2 1 Department of Medical and Surgical Sciences, DIMEC, Alma Mater Studiorum University of Bologna, Bologna, Italy. 2 Radiation Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. 3 Division of Urology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy

Purpose/Objective: